IPO Field Notes #01
A powder maker, two dentists and a twice-a-year asthma shot
Most new public investors have experienced finding out about an IPO through a rapid spike in a stock’s value or through an “explosion” of headlines. After learning about these companies, most new public investors want to know everything possible about the business.
In order to help you with this information while there is such limited coverage available, at IPO Field Notes, we provide this information for you. We will also review and cover these companies every approximately two weeks (or sooner if necessary) to identify who possess unique business models, technological advancements worth investigating, or products that people outside of Wall Street recognize and understand.
Like all Operators/CEOs evaluating potential investments, we examine how each company generates revenue, how its product(s)/service(s) works and who ultimately pays for its product/service(s).
In addition, we analyze whether the company generates positive cash flows.
Our analysis provides details regarding the business model, current share price, and what the management team has yet to accomplish.
Amaero (AMRO)
Nasdaq · First U.S. trade: October 15, 2026
Amaero began in 2013 when it spun out of Monash University, where it was based in Melbourne. It went public in Australia in 2019. In 2023, Amaero shut down all operations in Australia and is rebuilding in Tennessee on a single product line: creating metal powders for U.S. defense companies that want to buy from a U.S.-based source.

